After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. After-hours trades for DENTSPLY SIRONA Inc. (XRAY) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.05, or 0.12%, to $42.44. The DENTSPLY SIRONA Inc. has recorded 22,840 volume in the after hours trading session. Recently, Yahoo Finance discussed the stock, revealing that Dentsply Sirona, FDI World Dental Federation and Smile Train deliver the first-ever global protocols for digital cleft treatment.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
Sponsored
Stocks Info
DENTSPLY SIRONA Inc. is listed on the NASDAQ in the Healthcare sector while operating in the Medical Instruments & Supplies industry. At the end of the last regular session, the stock closed at $42.39 and fluctuated between $42.43 as its day high and $41.65 as its day low. The current market capitalization of DENTSPLY SIRONA Inc. is $8.88B. A total of 1.52 million shares were traded on the day, compared to an average of 2.01M shares.
Insider Activity
Insider trades are also considered as indicators of how a stock will perform in the future, in addition to stock predictions. During the recent three months, XRAY has seen 9 BUY and 4 SELL insider trades, representing the acquisition of 134,326 and the disposition of 7,341 shares. Over the last 12 months, there were 76 BUYs and 18 SELLs from insiders. Insiders purchased 1,192,140 shares during that period but sold 134,879.
In the most recent transaction, Staehler Cord Friedrich sold 4,000 shares of XRAY for 39.33 per share on Mar 07. After the transaction, the SVP, Chief Technology Officer now owns 97,693 company shares. In a previous transaction on Nov 15, LUCIER GREGORY T bought 6,000 shares at 31.45 per share. XRAY shares that Director owns now total 15,000.
Among the insiders who sold shares, BRANDT ERIC disposed of 6,900 shares on May 03 at a per-share price of $39.71. This resulted in the Director holding 35,155 shares of XRAY after the transaction.
Dividend
The reasons why investors prefer dividend-paying companies are that dividends generate immediate cash flow and indicate that the company will perform well in the future. XRAY’s most recent ex-dividend date was 3/30/2023 when it declared a $0.1250 quarterly dividend that was paid in cash on 4/14/2023. Previously, the company paid the dividend on 1/13/2023 with an ex-dividend date of 12/29/2022. The XRAY stock dividend was $0.1250 per share in cash.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. According to analysts who have offered 12-month price targets for XRAY in the last 3 months, the mean price target is $40.64 with high estimates of $45.00 and low estimates of $36.00. In terms of 52-week highs and lows, XRAY has a high of $42.24 and a low of $26.48.
As of this writing, XRAY has an earnings estimate of $0.34 per share for the current quarter. EPS was calculated based on a consensus of 12 estimates, with a high estimate of $0.37 per share and a lower estimate of $0.32. The company reported an EPS of $0.41 in the last quarter, which was -28.10% lower than expectations of $0.57.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. XRAY’s latest balance sheet shows that the firm has $339.00M in Cash & Short Term Investments as of fiscal 2021. There were $2.24B in debt and $1.19B in liabilities at the time. Its Book Value Per Share was $17.71, while its Total Shareholder’s Equity was $5.04B.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 13 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for XRAY is Hold with a score of 3.70. A total of 5 analysts rated the stock as Buy while 0 rated it as Overweight while 8 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.
